ARCHIVES

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

This article is from The Cancer Letter archive.

Vol. 33 No. 38 | October 19, 2007

Download PDF Visit The Full Archive

Related Articles

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

White House Plans to Name Broder NCI Director, Overruling Wyngaarden, Who Support Rabson

December 2, 1988

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Demonstration project to yield useful data, Peter Bach says.

June 3, 2005